GS 4104 neuraminidase inhibitor data

GILD and partner F. Hoffmann-La Roche Ltd. (Basel, Switzerland) presented statistically significant results of Phase II trials that tested the ability of an oral neuraminidase

Read the full 253 word article

How to gain access

Continue reading with a
two-week free trial.